Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
775
-
Total 13F shares, excl. options
-
324M
-
Shares change
-
+4.06M
-
Total reported value, excl. options
-
$12.4B
-
Value change
-
+$151M
-
Put/Call ratio
-
0.38
-
Number of buys
-
353
-
Number of sells
-
-294
-
Price
-
$38.21
Significant Holders of GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) as of Q3 2021
867 filings reported holding GSK - GLAXOSMITHKLINE PLC - SPONSORED ADR as of Q3 2021.
GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) has 775 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 324M shares
.
Largest 10 shareholders include Dodge & Cox (88M shares), Capital International Investors (22.7M shares), Fisher Asset Management, LLC (17.8M shares), FMR LLC (17.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (14.8M shares), Black Creek Investment Management Inc. (10.3M shares), RENAISSANCE TECHNOLOGIES LLC (9.41M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (9.13M shares), STATE STREET CORP (9.08M shares), and UBS Group AG (7.24M shares).
This table shows the top 775 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.